1. Altria's FQ1 earnings report highlighted profit pressures and growth challenges, with smokeable product sales declining due to insufficient pricing power to offset volume drops; 2. Oral tobacco products saw modest growth, led by an 18% shipment volume increase in the 'on!' franchise; 3. The company's total shareholder yield is expected to exceed 10%, supported by dividends, buybacks, and debt reduction efforts.
Related Articles
- Novo Nordisk: Enough Is Enough2 days ago
- Verizon Communications Remains A Compelling Value Playabout 1 month ago
- S&P 500 Earnings: Nothing Much This Week, But Don't Ignore Non-Correlatedabout 1 month ago
- Nvidia Q1 Earnings Review: China Restrictions Getting Worse2 months ago
- Okta Earnings: Growth Slows, But Financial Strength Stands Out3 months ago
- Nvidia: Roaring Into Q1 Earnings Release After Unjustified Pullback3 months ago
- Palantir: How I'm Betting On Its Continued Explosive U.S. Commercial Growth3 months ago
- ConocoPhillips: Just Too Many Headwinds3 months ago
- BHP Group: Long-Standing Preference For Rio Tinto, Neutral Rating Confirmed6 months ago
- Cisco Q2: Strong AI Infrastructure Order Growth6 months ago